Sparsentan can be used as option to treat primary immunoglobulin A nephropathy (IgAN) in adults with a:

  • urine protein excretion of 1.0 g/day or more, or
  • urine protein-to-creatinine ratio (UPCR) of 0.75 g/g or more. (TA1074)

 

Pack
30 tablet
Pack
30 tablet